The neuron-specific isoform of glycogen synthase kinase-3beta is required for axon growth
- PMID: 20067585
- DOI: 10.1111/j.1471-4159.2010.06581.x
The neuron-specific isoform of glycogen synthase kinase-3beta is required for axon growth
Abstract
Glycogen synthase kinase-3 (GSK-3) has become an important target for the treatment of mood disorders and neurodegenerative disease. It comprises three enzymes, GSK-3alpha, beta and the neuron-specific isoform, beta2. GSK-3 regulates axon growth by phosphorylating microtubule-associated proteins including Tau. A genetic polymorphism that leads to an increase in the ratio of GSK-3beta1 to GSK-3beta2 interacts with Tau haplotypes to modify disease risk in Parkinson's and Alzheimer's disease. We have examined the roles of each isoform of GSK-3 in neurons. Silencing of GSK-3beta2 inhibited retinoic acid-induced neurite outgrowth in SH-SY5Y neuroblastoma cells and axon growth in rat cortical neurons. Inhibition of neurite outgrowth was prevented by co-expression of GSK-3beta2 but not by co-expression of GSK-3alpha or GSK-3beta1. Ectopic expression GSK-3beta2 enhanced the effects of retinoic acid on neurite length and induced neurite formation in the absence of retinoic acid. GSK-3beta2 phosphorylated Tau at a subset of those sites phosphorylated by GSK-3beta1. In addition, Axin, which regulates responses to Wnt signals, associated more readily with GSK-3beta1 than with GSK-3beta2. Our results suggest that GSK-3 inhibitors that target the Axin-binding site in GSK-3 will preserve the beneficial effects of GSK-3beta2 on axon growth.
Similar articles
-
An alternatively spliced form of glycogen synthase kinase-3beta is targeted to growing neurites and growth cones.Mol Cell Neurosci. 2009 Nov;42(3):184-94. doi: 10.1016/j.mcn.2009.07.002. Epub 2009 Jul 14. Mol Cell Neurosci. 2009. PMID: 19607922
-
Glycogen synthase kinase-3β2 has lower phosphorylation activity to tau than glycogen synthase kinase-3β1.Biol Pharm Bull. 2011;34(1):146-9. doi: 10.1248/bpb.34.146. Biol Pharm Bull. 2011. PMID: 21212533
-
Glycogen synthase kinase-3 and Axin function in a beta-catenin-independent pathway that regulates neurite outgrowth in neuroblastoma cells.Mol Cell Neurosci. 2003 Nov;24(3):673-86. doi: 10.1016/s1044-7431(03)00229-x. Mol Cell Neurosci. 2003. PMID: 14664817
-
Pharmacological inhibitors of glycogen synthase kinase 3.Trends Pharmacol Sci. 2004 Sep;25(9):471-80. doi: 10.1016/j.tips.2004.07.006. Trends Pharmacol Sci. 2004. PMID: 15559249 Review.
-
[Advancement of cytoskeleton and axon outgrowth of neuron].Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi. 2010 Aug;24(8):997-1003. Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi. 2010. PMID: 20839453 Review. Chinese.
Cited by
-
Mitochondrial translation failure represses cholesterol gene expression via Pyk2-Gsk3β-Srebp2 axis.Life Sci Alliance. 2024 May 8;7(7):e202302423. doi: 10.26508/lsa.202302423. Print 2024 Jul. Life Sci Alliance. 2024. PMID: 38719751 Free PMC article.
-
A Diagnostic Model for Parkinson's Disease Based on Anoikis-Related Genes.Mol Neurobiol. 2024 Jun;61(6):3641-3656. doi: 10.1007/s12035-023-03753-6. Epub 2023 Nov 25. Mol Neurobiol. 2024. PMID: 38001358
-
Anti-Inflammatory Effect of IKK-Activated GSK-3β Inhibitory Peptide Prevented Nigrostriatal Neurodegeneration in the Rodent Model of Parkinson's Disease.Int J Mol Sci. 2022 Jan 17;23(2):998. doi: 10.3390/ijms23020998. Int J Mol Sci. 2022. PMID: 35055183 Free PMC article.
-
GSK-3 and Tau: A Key Duet in Alzheimer's Disease.Cells. 2021 Mar 24;10(4):721. doi: 10.3390/cells10040721. Cells. 2021. PMID: 33804962 Free PMC article. Review.
-
Recent Advances on the Role of GSK3β in the Pathogenesis of Amyotrophic Lateral Sclerosis.Brain Sci. 2020 Sep 26;10(10):675. doi: 10.3390/brainsci10100675. Brain Sci. 2020. PMID: 32993098 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Molecular Biology Databases
Miscellaneous